title: [Editor's commentary].
authors.affiliation: Semmelweis Egyetem, Általános Orvostudományi Kar Szemészeti Klinika Budapest Mária u. 39. 1085.
authors.forename: Ildikó
authors.initials: I
authors.lastname: Süveges
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure; D002196:Capillaries / Q000187:drug effects; D002387:Cataract Extraction; D003261:Contact Lenses / Q000639:trends; D005123:Eye / Q000098:blood supply*; D006801:Humans; D006814:Hungary; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D033183:Interdisciplinary Communication; D007429:Intraocular Pressure; D009885:Ophthalmology / Q000639:trends*; D009907:Optometry / Q000639:trends; D000069579:Ranibizumab; D012017:Referral and Consultation; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab